You can purchase shares of Amicus Therapeutics (NASDAQ:FOLD) through any online brokerage.

View our list of the best stock brokerages

Other companies in Amicus Therapeutics’s space includes: Immunovant Inc (NASDAQ:IMVT), Legend Biotech Corp (NASDAQ:LEGN), Centessa Pharmaceuticals PLC (NASDAQ:CNTA), Xenon Pharmaceuticals Inc (NASDAQ:XENE) and Alkermes PLC (NASDAQ:ALKS).

Amicus Therapeutics has a consensus price target of $22.92.

The stock price for Amicus Therapeutics (NASDAQ: FOLD) is $14.43 last updated March 26, 2026 at 4:00 PM EDT.

There are no upcoming dividends for Amicus Therapeutics.

Amicus Therapeutics does not have any upcoming earnings scheduled.

There is no upcoming split for Amicus Therapeutics.

Amicus Therapeutics is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.